| Authors: |
Kawatkar A; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States., Clark RA; Discovery Sciences, R&D, AstraZeneca, CambridgeCB2 0AA, U.K., Hopcroft L; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K., Roaquin DA; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States., Tomlinson R; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States., Zuhl AM; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States., Lamont GM; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K., Kettle JG; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K., Critchlow SE; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K., Castaldi MP; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States., Goldberg FW; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K., Zhang AX; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States. |